Differential efficacy of a synthetic antagonist of VLA-4 during the course of chronic relapsing experimental autoimmune encephalomyelitis

被引:19
作者
Cannella, B
Gaupp, S
Tilton, RG
Raine, CS
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol Neuropathol, Bronx, NY 10461 USA
[2] Texas Biotechnol Corp, Houston, TX USA
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY USA
[4] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY USA
关键词
adhesion molecules; CNS autoimmunity; myelin; multiple sclerosis;
D O I
10.1002/jnr.10487
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The integrin VLA-4 has been shown to play a key role in the entry of antigen-specific T cells into the CNS during autoimmune demyelination. Treatment of animals with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, with antibodies to VLA-4 is known to suppress acute disease. In the present study, a synthetic antagonist of VLA-4 (TBC 3486) was injected subcutaneously into mice adoptively sensitized for chronic relapsing EAE. TBC 3486 was administered daily for 14 days at early (before acute signs) and late time points (during chronic disease). Early treatment led to marked delay in disease onset and reduction in clinical severity and demyelination. After termination of treatment, clinical severity remained lower than in controls for more than 1 week. TBC 3486-treated animals showing no clinical signs (at the height of disease in controls) displayed moderate levels of inflammation but little damage to myelin. Late administration of TBC 3486 to animals with chronic EAE had no effect clinically. Immunocytochemistry and Western blotting of CNS tissue from acutely treated animals supported a moderate shift toward a Th2-type cytokine profile after treatment. Thus, TBC 3486 effectively delayed and reduced the acute (but not chronic) phase of EAE, and this amelioration correlated with changes in the inflammatory molecule profile. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:407 / 416
页数:10
相关论文
共 28 条
[1]   CYTOKINES IN THE CENTRAL-NERVOUS-SYSTEM OF MICE DURING CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
BAKER, D ;
ONEILL, JK ;
TURK, JL .
CELLULAR IMMUNOLOGY, 1991, 134 (02) :505-510
[2]  
Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013
[3]  
Begolka WS, 1998, J IMMUNOL, V161, P4437
[4]   Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment [J].
Brocke, S ;
Piercy, C ;
Steinman, L ;
Weissman, IL ;
Veromaa, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6896-6901
[5]  
Cannella B, 1996, J NEUROSCI RES, V45, P735, DOI 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO
[6]  
2-V
[7]  
CANNELLA B, 1991, LAB INVEST, V65, P23
[8]   THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS [J].
CANNELLA, B ;
RAINE, CS .
ANNALS OF NEUROLOGY, 1995, 37 (04) :424-435
[9]   The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis [J].
Cannella, B ;
Hoban, CJ ;
Gao, YL ;
Garcia-Arenas, R ;
Lawson, D ;
Marchionni, M ;
Gwynne, D ;
Raine, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10100-10105
[10]   Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment [J].
Carrithers, MD ;
Visintin, I ;
Kang, SJ ;
Janeway, CA .
BRAIN, 2000, 123 :1092-1101